ECMO用カニューレの市場規模、シェア、動向分析レポート：タイプ別、患者タイプ別、用途別、最終用途別、地域別、セグメント予測、2024年～2030年

ECMO用カニューレ市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、ECMO用カニューレの世界市場規模は、2024年から2030年にかけて4.6％のCAGRを記録し、2030年には4,380万米ドルに達すると予測されています。

呼吸器疾患と心臓疾患の有病率の増加が市場成長の主な要因です。例えば、2023年11月、中国の国家衛生委員会は呼吸器疾患の増加を指摘し、その原因はCOVID-19対策の緩和とインフルエンザ、マイコプラズマ肺炎、呼吸器合胞体ウイルス（RSV）、SARS-CoV-2などの身近な病原体の存在にあるとしました。世界の医療情勢は、高齢者人口の拡大から大きな影響を受けており、心臓や肺の病気など、加齢に伴う病気の急増につながっています。

世界保健機関（WHO）は、2030年までに世界の6人に1人が60歳以上になり、この年齢層の人口は2020年の10億人から14億人に増加すると予測しています。うっ血性心不全、慢性閉塞性肺疾患（COPD）、肺線維症などの病態は、しばしば呼吸不全や心不全に至り、ECMO療法のような高度な生命維持介入を必要とします。このように、これらの病態の蔓延は、高齢化する人口の進化するニーズに対応するための医療インフラとサービスの強化の重要性を世界的に浮き彫りにしています。さらにECMOは、心肺蘇生法（CPR）のような従来の介入では成功しなかった心不全や呼吸不全の場合に利用されます。

ECMOの利用は、体外式CO2除去（ECCO2R）、小児・新生児ケア、回復や移植への導管としての役割、院内搬送の促進、心停止の管理、心不全と呼吸不全の両方への対応など、さまざまな医療シナリオに及んでいます。さらに、クリティカルケア環境において、ECMOによる院内搬送が受け入れられつつあります。米国国立衛生研究所（NIH）が2023年8月に発表した論文によると、肥満症の成人は、呼吸不全の集中治療中に、高度な呼吸補助法である体外膜酸素療法（ECMO）が有益であると考えられます。したがって、ECMOの用途拡大が市場成長に寄与すると予想されます。

ECMO用カニューレ市場レポート・ハイライト

• 静脈-動脈タイプセグメントは2023年に約45%の最大シェアを占め、循環および呼吸機能のための静脈-動脈（VA）ECMOシステム&回路の幅広い使用により、2024年から2030年にかけてCAGR 5.0%の最速成長が見込まれます。
• 成人患者タイプセグメントは、2023年に約64％の最大シェアを占め、ARDSなどの呼吸器疾患を患う患者が多いことから、2024年から2030年にかけて最も急成長が見込まれています。
• 呼吸器用途セグメントは、呼吸窮迫症候群、呼吸不全、肺炎、肺高血圧症などのさまざまな呼吸器疾患におけるECMOの広範な使用により、2023年に約47％の最大シェアを占めました。
• 体外心肺蘇生法（ECPR）セグメントは、従来の心肺蘇生法に反応しない心停止患者の治療にECPRの使用が増加しているため、2024年から2030年までのCAGRが5.25%と最も速くなります。
• 病院の最終用途セグメントは、一つ屋根の下で様々なサービスを利用できるため、治療や手術に好まれており、2023年には54.69％のシェアで支配的でした。
• 外来手術センターセグメントは、2024年から2030年にかけて最も速いCAGRで成長すると予想されています。
• 2021年2月、MedtronicはFDAのガイドラインに従い、COVID-19に対応するためクリティカルケア製品を一時的に修正しました。Bio-Medicus Adult Cannula and Introducers、Bio-Medicus Cannula Kits、Bio-Medicus Pediatric Cannulaなどの製品は、COVID-19に対応するため、ECMO療法での長時間使用をサポートするように変更されました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 ECMO用カニューレ市場の変数と動向

• 市場系統の見通し
• 市場力学
  • 市場促進要因の影響分析
  • 市場抑制要因の影響分析
• 業界分析ツール
  • ポーターの分析
  • マクロ経済分析

第4章 ECMO用カニューレ市場：タイプ分析

• タイプの変動分析と市場シェア、2023年と2030年
• タイプ別
• 市場規模と予測・動向分析、2018年～2030年

第5章 ECMO用カニューレ市場：患者タイプ分析

• 患者タイプの変動分析と市場シェア、2023年と2030年
• 患者タイプ別
• 市場規模と予測・動向分析、2018年～2030年

第6章 ECMO用カニューレ市場：用途分析

• 用途の変動分析と市場シェア、2023年と2030年
• 用途別
• 市場規模と予測・動向分析、2018年～2030年

第7章 ECMO用カニューレ市場：最終用途分析

• 最終用途の変動分析と市場シェア、2023年と2030年
• 最終用途別
• 市場規模と予測・動向分析、2018年～2030年

第8章 ECMO用カニューレ市場：地域の推定・動向分析

• ECMO用カニューレ市場：地域別展望
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合分析

• 企業分類
• 参入企業の概要
• 財務実績
• 企業ポジショニング分析
• 製品ベンチマーキング
• 戦略マッピング
• 企業プロファイル
  • Medtronic
  • LivaNova PLC
  • Edwards Lifesciences Corporation
  • Getinge
  • Andocor
  • Changzhou KangXin Medical Instruments Co., Ltd
  • Free Life Medical GmbH
  • Fresenius Medical Care AG
  • Abbott

第10章 アナリストの視点

List of Tables

• Table 1 List of abbreviations
• Table 2 North America extracorporeal membrane oxygenation (ECMO) cannula market, by region, 2018 - 2030 (USD Million)
• Table 3 North America extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 4 North America extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 5 North America extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 6 North America extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 7 U.S. extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 8 U.S. extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 9 U.S. extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 10 U.S. extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 11 Canada extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 12 Canada extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 13 Canada extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 14 Canada extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 15 Europe extracorporeal membrane oxygenation (ECMO) cannula market, by region, 2018 - 2030 (USD Million)
• Table 16 Europe extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 17 Europe extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 18 Europe extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 19 Europe extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 20 Germany extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 21 Germany extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 22 Germany extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 23 Germany extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 24 UK extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 25 UK extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 26 UK extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 27 UK extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 28 France extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 29 France extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 30 France extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 31 France extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 32 Italy extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 33 Italy extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 34 Italy extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 35 Italy extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 36 Spain extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 37 Spain extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 38 Spain extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 39 Spain extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 40 Denmark extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 41 Denmark extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 42 Denmark extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 43 Denmark extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 44 Sweden extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 45 Sweden extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 46 Sweden extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 47 Sweden extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 48 Norway extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 49 Norway extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 50 Norway extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 51 Norway extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 52 Asia Pacific extracorporeal membrane oxygenation (ECMO) cannula market, by region, 2018 - 2030 (USD Million)
• Table 53 Asia Pacific extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 54 Asia Pacific extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 55 Asia Pacific extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 56 Asia Pacific extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 57 China extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 58 China extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 59 China extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 60 China extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 61 Japan extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 62 Japan extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 63 Japan extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 64 Japan extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 65 India extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 66 India extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 67 India extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 68 India extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 69 Australia extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 70 Australia extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 71 Australia extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 72 Australia extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 73 South Korea extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 74 South Korea extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 75 South Korea extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 76 South Korea extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 77 Thailand extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 78 Thailand extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 79 Thailand extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 80 Thailand extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 81 Latin America extracorporeal membrane oxygenation (ECMO) cannula market, by region, 2018 - 2030 (USD Million)
• Table 82 Latin America extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 83 Latin America extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 84 Latin America extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 85 Latin America extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 86 Brazil extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 87 Brazil extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 88 Brazil extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 89 Brazil extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 90 Mexico extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 91 Mexico extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 92 Mexico extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 93 Mexico extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 94 Argentina extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 95 Argentina extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 96 Argentina extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 97 Argentina extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 98 MEA extracorporeal membrane oxygenation (ECMO) cannula market, by region, 2018 - 2030 (USD Million)
• Table 99 MEA extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 100 MEA extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 101 MEA extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 102 MEA extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 103 South Africa extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 104 South Africa extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 105 South Africa extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 106 South Africa extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 107 Saudi Arabia extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 108 Saudi Arabia extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 109 Saudi Arabia extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 110 Saudi Arabia extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 111 UAE extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 112 UAE extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 113 UAE extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 114 UAE extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)
• Table 115 Kuwait extracorporeal membrane oxygenation (ECMO) cannula market, by type, 2018 - 2030 (USD Million)
• Table 116 Kuwait extracorporeal membrane oxygenation (ECMO) cannula market, by patient type, 2018 - 2030 (USD Million)
• Table 117 Kuwait extracorporeal membrane oxygenation (ECMO) cannula market, by application, 2018 - 2030 (USD Million)
• Table 118 Kuwait extracorporeal membrane oxygenation (ECMO) cannula market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Extracorporeal Membrane Oxygenation (ECMO) cannula market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 Market formulation & validation
• Fig. 8 Market snapshot, USD Million
• Fig. 9 Segment snapshot (Type and Patient Type )
• Fig. 10 Segment snapshot (Application and End Use)
• Fig. 11 Competitive landscape
• Fig. 12 Cannula and ECMO cannula market value, 2023 (USD million)
• Fig. 13 Extracorporeal Membrane Oxygenation (ECMO) cannula market dynamics
• Fig. 14 Extracorporeal Membrane Oxygenation (ECMO) cannula market: PORTER's analysis
• Fig. 15 Extracorporeal Membrane Oxygenation (ECMO) cannula market: PESTEL analysis
• Fig. 16 Extracorporeal Membrane Oxygenation (ECMO) cannula market by type: Key takeaways
• Fig. 17 Extracorporeal Membrane Oxygenation (ECMO) cannula market, by type: Market share, 2023 & 2030
• Fig. 18 Veno-arterial market, 2018 - 2030 (USD Million)
• Fig. 19 Veno-venous market, 2018 - 2030 (USD Million)
• Fig. 20 Arterio-venous market, 2018 - 2030 (USD Million)
• Fig. 21 Extracorporeal Membrane Oxygenation (ECMO) cannula market by patient type: Key takeaways
• Fig. 22 Extracorporeal Membrane Oxygenation (ECMO) cannula market, by patient type: Market share, 2023 & 2030
• Fig. 23 Adult market, 2018 - 2030 (USD Million)
• Fig. 24 Pediatric market, 2018 - 2030 (USD Million)
• Fig. 25 Neonates market, 2018 - 2030 (USD Million)
• Fig. 26 Extracorporeal Membrane Oxygenation (ECMO) cannula market by application: Key takeaways
• Fig. 27 Extracorporeal Membrane Oxygenation (ECMO) cannula market, by application: Market share, 2023 & 2030
• Fig. 28 Respiratory market, 2018 - 2030 (USD Million)
• Fig. 29 Cardiac market, 2018 - 2030 (USD Million)
• Fig. 30 ECPR market, 2018 - 2030 (USD Million)
• Fig. 31 Extracorporeal Membrane Oxygenation (ECMO) cannula market by end use: Key takeaways
• Fig. 32 Extracorporeal Membrane Oxygenation (ECMO) cannula market, by end use: Market share, 2023 & 2030
• Fig. 33 Hospitals market, 2018 - 2030 (USD Million)
• Fig. 34 Ambulatory surgical centers market, 2018 - 2030 (USD Million)
• Fig. 35 Others market, 2018 - 2030 (USD Million)
• Fig. 36 Extracorporeal Membrane Oxygenation (ECMO) cannula market revenue, by region, 2023 & 2030 (USD Million)
• Fig. 37 Regional marketplace: Key takeaways
• Fig. 38 Regional marketplace: Key takeaways
• Fig. 39 North America Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Key country dynamics
• Fig. 41 Reimbursement procurement process
• Fig. 42 U.S. Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Key country dynamics
• Fig. 44 Number of key elements by type of center, 2021
• Fig. 45 Canada Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 Europe Extracorporeal Membrane Oxygenation (ECMO) Cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Key country dynamics
• Fig. 48 Germany Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 Key country dynamics
• Fig. 50 UK Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Key country dynamics
• Fig. 52 France Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Key country dynamics
• Fig. 54 Italy Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Key country dynamics
• Fig. 56 Spain Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Key country dynamics
• Fig. 58 Denmark Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Key country dynamics
• Fig. 60 Sweden Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Key country dynamics
• Fig. 62 Norway Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Asia Pacific Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Key country dynamics
• Fig. 65 Reimbursement procurement process
• Fig. 66 Japan Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Key country dynamics
• Fig. 68 China Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Key country dynamics
• Fig. 70 India Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Key country dynamics
• Fig. 72 Australia Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 73 Key country dynamics
• Fig. 74 South Korea Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Key country dynamics
• Fig. 76 Thailand Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Latin America Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Key country dynamics
• Fig. 79 Brazil Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Key country dynamics
• Fig. 81 Mexico Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Key country dynamics
• Fig. 83 Argentina Extracorporeal Membrane Oxygenation (ECMO) Cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Middle East & Africa Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 85 Key country dynamics
• Fig. 86 South Africa Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 87 Key country dynamics
• Fig. 88 Saudi Arabia Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 89 Key country dynamics
• Fig. 90 UAE Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 91 Key country dynamics
• Fig. 92 Kuwait Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 93 Key company categorization
• Fig. 94 Company positioning analysis
• Fig. 95 Strategy mapping

Extracorporeal Membrane Oxygenation Cannula Market Growth & Trends:

The global extracorporeal membrane oxygenation cannula market size is anticipated to reach USD 43.8 million by 2030, registering a CAGR of 4.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing prevalence of respiratory & cardiac disorders is the major factor contributing to market growth. For instance, in November 2023, the National Health Commission in China noted a rise in respiratory illnesses, attributing it to the relaxation of COVID-19 measures and the presence of familiar pathogens like influenza, mycoplasma pneumonia, respiratory syncytial virus (RSV), and SARS-CoV-2. The global healthcare landscape is significantly influenced by the expanding elderly population, leading to a surge in age-related ailments, such as heart and lung diseases.

The World Health Organization (WHO) predicted that by 2030, one in every six people worldwide will be aged 60 years or older, with the population in this age group projected to increase from 1 billion in 2020 to 1.4 billion. Conditions, such as congestive heart failure, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis, frequently culminate in respiratory or cardiac failure, often necessitating advanced life support interventions like ECMO therapy. As such, the prevalence of these conditions underscores the importance of enhancing healthcare infrastructure and services to cater to the evolving needs of aging populations globally. Moreover, ECMO is utilized in instances of cardiac or respiratory failure when conventional interventions like Cardiopulmonary Resuscitation (CPR) have not yielded success.

Its utilization spans a spectrum of medical scenarios, encompassing Extracorporeal CO2 Removal (ECCO2R), pediatric and neonatal care, acting as a conduit to recovery or transplantation, facilitating in-hospital transport, managing cardiac arrest, and addressing both cardiac and respiratory failure. Furthermore, there has been a growing acceptance of ECMO for in-hospital transport within critical care environments. As per an article published by the National Institute of Health (NIH) in August 2023, adults suffering from obesity may find extracorporeal membrane oxygenation (ECMO), an advanced form of respiratory support, beneficial during intensive care for respiratory failure. Hence, the growing applications of ECMO are expected to contribute to market growth.

Extracorporeal Membrane Oxygenation Cannula Market Report Highlights:

• The veno-arterial type segment held the largest share of around 45% in 2023 and is expected to grow at the fastest CAGR of 5.0% from 2024 to 2030 owing to the wide use of Veno-Arterial (VA) ECMO systems & circuits for circulatory and respiratory functions
• The adult patient type segment held the largest share of around 64% in 2023 and is anticipated to witness the fastest growth from 2024 to 2030 due to many patients suffering from respiratory conditions, such as ARDS
• The respiratory application segment accounted for the largest share of around 47% in 2023 due to the extensive use of ECMO in various respiratory conditions, such as respiratory distress syndrome, respiratory failure, pneumonia, and pulmonary hypertension In addition, the high prevalence of these conditions will propel the segment growth further
• The Extracorporeal Cardiopulmonary Resuscitation (ECPR) segment will witness the fastest CAGR of 5.25% from 2024 to 2030 due to the rising use of ECPR for treating patients with cardiac arrest who do not respond to conventional cardiopulmonary resuscitation
• The hospitals end-use segment dominated with a 54.69% share in 2023 as they are preferred for treatments and surgeries due to the availability of various services under one roof
• The ambulatory surgical centers segment is expected to grow at the fastest CAGR from 2024 to 2030
• In February 2021, Medtronic temporarily modified its critical care products to address COVID-19 as per the guidelines of the FDA. Products such as Bio-Medicus Adult Cannula and Introducers, Bio-Medicus Cannula Kits, & Bio-Medicus Pediatric Cannula were modified to support longer-duration use in ECMO therapy to address COVID-19

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation
• 1.2 Market Definition
  • 1.2.1 Type
  • 1.2.2 Patient Type
  • 1.2.3 Application
• 1.3 Research Methodology
• 1.4 Information Procurement
  • 1.4.1 Purchased Database
  • 1.4.2 Gvr's Internal Database
  • 1.4.3 Secondary Sources
  • 1.4.4 Primary Research
• 1.5 Information or Data Analysis
  • 1.5.1 Data Analysis Models
• 1.6 Market Formulation & Validation
• 1.7 Model Details
  • 1.7.1 Commodity Flow Analysis
• 1.8 List of Secondary Sources
• 1.9 List of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective 1
  • 1.10.2 Objective 2
  • 1.10.3 Objective 3

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Segment Snapshot
• 2.3 Segment Snapshot
• 2.4 Competitive Landscape

Chapter 3 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market Variables and Trends

• 3.1 Market Lineage Outlook
• 3.2 Market Dynamics
  • 3.2.1 Market Driver Impact Analysis
    • 3.2.1.1 Increasing prevalence of respiratory and cardiac disorders
    • 3.2.1.2 Rising geriatric population
    • 3.2.1.3 Rising applications in ECMO
  • 3.2.2 Market Restraint Impact Analysis
    • 3.2.2.1 Risks associated with ECMO
• 3.3 Industry Analysis Tools
  • 3.3.1 Porter's Analysis
  • 3.3.2 Macroeconomic Analysis

Chapter 4 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market: Type Analysis

• 4.1 Type Movement Analysis & Market Share, 2023 & 2030
• 4.2 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market Estimates & Forecast, by Type (USD Million)
• 4.3 Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 4.3.1 Veno-Arterial
    • 4.3.1.1 Veno-Arterial Market, 2018 - 2030 (USD Million)
  • 4.3.2 Veno-Venous
    • 4.3.2.1 Veno-Venous Market, 2018 - 2030 (USD Million)
  • 4.3.3 Arterio-Venous
    • 4.3.3.1 Arterio-venous market, 2018 - 2030 (USD Million)

Chapter 5 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market: Patient Type Analysis

• 5.1 Patient Type Movement Analysis & Market Share, 2023 & 2030
• 5.2 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market Estimates & Forecast, by Patient Type (USD Million)
• 5.3 Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 5.3.1 Adult
    • 5.3.1.1 Adult Market, 2018 - 2030 (USD Million)
  • 5.3.2 Pediatric
    • 5.3.2.1 Pediatric market, 2018 - 2030 (USD Million)
  • 5.3.3 Neonates
    • 5.3.3.1 Neonates market, 2018 - 2030 (USD Million)

Chapter 6 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market: Application Analysis

• 6.1 Application Movement Analysis & Market Share, 2023 & 2030
• 6.2 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market Estimates & Forecast, by Application (USD Million)
• 6.3 Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 6.3.1 Respiratory
    • 6.3.1.1 Respiratory Market, 2018 - 2030 (USD Million)
  • 6.3.2 Cardiac
    • 6.3.2.1 Cardiac market, 2018 - 2030 (USD Million)
  • 6.3.3 ECPR
    • 6.3.3.1 ECPR market, 2018 - 2030 (USD Million)

Chapter 7 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market: End-use Analysis

• 7.1 End-use Movement Analysis & Market Share, 2023 & 2030
• 7.2 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market Estimates & Forecast, by End-use (USD Million)
• 7.3 Market Size & Forecasts and Trend Analysis, 2018 to 2030
  • 7.3.1 Hospitals
    • 7.3.1.1 Hospitals Market, 2018 - 2030 (USD Million)
  • 7.3.2 Ambulatory Surgical Centers
    • 7.3.2.1 Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • 7.3.3 Others
    • 7.3.3.1 Others market, 2018 - 2030 (USD Million)

Chapter 8 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market: Regional Estimates & Trend Analysis

• 8.1 Extracorporeal Membrane Oxygenation (ECMO) Cannula Market: Regional Outlook
• 8.2 North America
  • 8.2.1 North America Extracorporeal Membrane Oxygenation (Ecmo) Cannula Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.2.2 U.S.
    • 8.2.2.1 Key Country Dynamics
    • 8.2.2.2 Competitive Scenario
    • 8.2.2.3 Regulatory Scenario
    • 8.2.2.4 Reimbursement Scenario
    • 8.2.2.5 U.S. Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.2.3 Canada
    • 8.2.3.1 Key Country Dynamics
    • 8.2.3.2 Competitive Scenario
    • 8.2.3.3 Regulatory Framework
    • 8.2.3.4 Reimbursement Scenario
    • 8.2.3.5 Canada Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.3 Europe
  • 8.3.1 Europe Extracorporeal Membrane Oxygenation (Ecmo) Cannula Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2 Germany
    • 8.3.2.1 Key Country Dynamics
    • 8.3.2.2 Competitive Scenario
    • 8.3.2.3 Regulatory Framework
    • 8.3.2.4 Reimbursement Scenario
    • 8.3.2.5 Germany Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.3.3 UK
    • 8.3.3.1 Key Country Dynamics
    • 8.3.3.2 Competitive Scenario
    • 8.3.3.3 Regulatory Framework
    • 8.3.3.4 Reimbursement Scenario
    • 8.3.3.5 UK Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.3.4 France
    • 8.3.4.1 Key Country Dynamics
    • 8.3.4.2 Competitive Scenario
    • 8.3.4.3 Regulatory Framework
    • 8.3.4.4 Reimbursement Scenario
    • 8.3.4.5 France Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.3.5 Italy
    • 8.3.5.1 Key Country Dynamics
    • 8.3.5.2 Competitive Scenario
    • 8.3.5.3 Regulatory Framework
    • 8.3.5.4 Reimbursement Scenario
    • 8.3.5.5 Italy Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.3.6 Spain
    • 8.3.6.1 Key Country Dynamics
    • 8.3.6.2 Competitive Scenario
    • 8.3.6.3 Regulatory Framework
    • 8.3.6.4 Reimbursement Scenario
    • 8.3.6.5 Spain Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.7 Denmark
    • 8.3.7.1 Key Country Dynamics
    • 8.3.7.2 Competitive Scenario
    • 8.3.7.3 Regulatory Framework
    • 8.3.7.4 Reimbursement Scenario
    • 8.3.7.5 Denmark Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.3.8 Sweden
    • 8.3.8.1 Key Country Dynamics
    • 8.3.8.2 Competitive Scenario
    • 8.3.8.3 Regulatory Framework
    • 8.3.8.4 Reimbursement Scenario
    • 8.3.8.5 Sweden Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.3.9 Norway
    • 8.3.9.1 Key Country Dynamics
    • 8.3.9.2 Competitive Scenario
    • 8.3.9.3 Regulatory Framework
    • 8.3.9.4 Reimbursement Scenario
    • 8.3.9.5 Norway Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.4 Asia Pacific
  • 8.4.1 Asia Pacific Ecmo Cannula Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2 Japan
    • 8.4.2.1 Key Country Dynamics
    • 8.4.2.2 Competitive Scenario
    • 8.4.2.3 Regulatory Framework
    • 8.4.2.4 Reimbursement Scenario
    • 8.4.2.5 Japan Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.3 China
    • 8.4.3.1 Key Country Dynamics
    • 8.4.3.2 Competitive Scenario
    • 8.4.3.3 Regulatory Framework
    • 8.4.3.4 Reimbursement Scenario
    • 8.4.3.5 China Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.4 India
    • 8.4.4.1 Key Country Dynamics
    • 8.4.4.2 Competitive Scenario
    • 8.4.4.3 Regulatory Framework
    • 8.4.4.4 Reimbursement Scenario
    • 8.4.4.5 India Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.5 Australia
    • 8.4.5.1 Key Country Dynamics
    • 8.4.5.2 Competitive Scenario
    • 8.4.5.3 Regulatory Framework
    • 8.4.5.4 Reimbursement Scenario
    • 8.4.5.5 Australia Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.6 South Korea
    • 8.4.6.1 Key Country Dynamics
    • 8.4.6.2 Competitive Scenario
    • 8.4.6.3 Regulatory Framework
    • 8.4.6.4 Reimbursement Scenario
    • 8.4.6.5 South Korea Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.4.7 Thailand
    • 8.4.7.1 Key Country Dynamics
    • 8.4.7.2 Competitive Scenario
    • 8.4.7.3 Regulatory Framework
    • 8.4.7.4 Reimbursement Scenario
    • 8.4.7.5 Thailand Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.5 Latin America
  • 8.5.1 Latin America Extracorporeal Membrane Oxygenation (Ecmo) Cannula Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2 Brazil
    • 8.5.2.1 Key Country Dynamics
    • 8.5.2.2 Competitive Scenario
    • 8.5.2.3 Regulatory Framework
    • 8.5.2.4 Reimbursement Scenario
    • 8.5.2.5 Brazil Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.3 Mexico
    • 8.5.3.1 Key Country Dynamics
    • 8.5.3.2 Competitive Scenario
    • 8.5.3.3 Regulatory Framework
    • 8.5.3.4 Reimbursement Scenario
    • 8.5.3.5 Mexico Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.5.4 Argentina
    • 8.5.4.1 Key Country Dynamics
    • 8.5.4.2 Competitive Scenario
    • 8.5.4.3 Regulatory Framework
    • 8.5.4.4 Reimbursement Scenario
    • 8.5.4.5 Argentina Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
• 8.6 Middle East & Africa
  • 8.6.1 Middle East & Africa Extracorporeal Membrane Oxygenation (Ecmo) Cannula Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2 South Africa
    • 8.6.2.1 Key Country Dynamics
    • 8.6.2.2 Competitive Scenario
    • 8.6.2.3 Regulatory Framework
    • 8.6.2.4 Reimbursement Scenario
    • 8.6.2.5 South Africa Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6.3 Saudi Arabia
    • 8.6.3.1 Key Country Dynamics
    • 8.6.3.2 Competitive Scenario
    • 8.6.3.3 Regulatory Framework
    • 8.6.3.4 Reimbursement Scenario
    • 8.6.3.5 Saudi Arabia Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6.4 UAE
    • 8.6.4.1 Key Country Dynamics
    • 8.6.4.2 Competitive Scenario
    • 8.6.4.3 Regulatory Framework
    • 8.6.4.4 Reimbursement Scenario
    • 8.6.4.5 UAE Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)
  • 8.6.5 Kuwait
    • 8.6.5.1 Key Country Dynamics
    • 8.6.5.2 Competitive Scenario
    • 8.6.5.3 Regulatory Framework
    • 8.6.5.4 Reimbursement Scenario
    • 8.6.5.5 Kuwait Extracorporeal Membrane Oxygenation (ECMO) cannula market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 9 Competitive Analysis

• 9.1 Company Categorization
• 9.2 Participants' Overview
• 9.3 Financial Performance
• 9.4 Company Positioning Analysis
• 9.5 Product Benchmarking
• 9.6 Strategy Mapping
  • 9.6.1 Mergers & Acquisitions
  • 9.6.2 Product Launch
  • 9.6.3 Product Approvals
  • 9.6.4 Others
• 9.7 Company Profiles
  • 9.7.1. Medtronic
    • 9.7.1.1. Company Overview
    • 9.7.1.2. Financial Performance
    • 9.7.1.3. Form Portfolios
    • 9.7.1.4. Strategic Initiatives
  • 9.7.2. LivaNova PLC
    • 9.7.2.1. Company Overview
    • 9.7.2.2. Financial Performance
    • 9.7.2.3. Form Portfolios
    • 9.7.2.4. Strategic Initiatives
  • 9.7.3. Edwards Lifesciences Corporation
    • 9.7.3.1. Company Overview
    • 9.7.3.2. Financial Performance
    • 9.7.3.3. Form Portfolios
    • 9.7.3.4. Strategic Initiatives
  • 9.7.4. Getinge
    • 9.7.4.1. Company Overview
    • 9.7.4.2. Financial Performance
    • 9.7.4.3. Form Portfolios
    • 9.7.4.4. Strategic Initiatives
  • 9.7.5. Andocor
    • 9.7.5.1. Company Overview
    • 9.7.5.2. Financial Performance
    • 9.7.5.3. Form Portfolios
    • 9.7.5.4. Strategic Initiatives
  • 9.7.6. Changzhou KangXin Medical Instruments Co., Ltd
    • 9.7.6.1. Company Overview
    • 9.7.6.2. Financial Performance
    • 9.7.6.3. Form Portfolios
    • 9.7.6.4. Strategic Initiatives
  • 9.7.7. Free Life Medical GmbH
    • 9.7.7.1. Company Overview
    • 9.7.7.2. Financial Performance
    • 9.7.7.3. Form Portfolios
    • 9.7.7.4. Strategic Initiatives
  • 9.7.8. Fresenius Medical Care AG
    • 9.7.8.1. Company Overview
    • 9.7.8.2. Financial Performance
    • 9.7.8.3. Form Portfolios
    • 9.7.8.4. Strategic Initiatives
  • 9.7.9. Abbott
    • 9.7.9.1. Company Overview
    • 9.7.9.2. Financial Performance
    • 9.7.9.3. Form Portfolios
    • 9.7.9.4. Strategic Initiatives

Chapter 10 Analyst Perspective